High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

about

C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion

P2860

Q28391156-4DE8BB6D-006E-43D1-AA5E-7C59C348E9E3

P2860

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

Item

http://www.wikidata.org/entity/Q38873431

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

High-throughput transcriptomic ...... ic targets in prostate cancer.

@en

type

Item

label

High-throughput transcriptomic ...... ic targets in prostate cancer.

@en

prefLabel

High-throughput transcriptomic ...... ic targets in prostate cancer.

@en

P1476

High-throughput transcriptomic ...... ic targets in prostate cancer.

@en

P2093

A E Ross

http://www.w3.org/2001/XMLSchema#string

C Speers

http://www.w3.org/2001/XMLSchema#string

D A Hamstra

http://www.w3.org/2001/XMLSchema#string

E A Klein

http://www.w3.org/2001/XMLSchema#string

E Davicioni

http://www.w3.org/2001/XMLSchema#string

E M Schaeffer

http://www.w3.org/2001/XMLSchema#string

F Y Feng

http://www.w3.org/2001/XMLSchema#string

J R Evans

http://www.w3.org/2001/XMLSchema#string

M J Schipper

http://www.w3.org/2001/XMLSchema#string

N Erho

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy

Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis.

Identification of prognostic biomarkers for prostate cancer.

A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

VCaP, a cell-based model system of human prostate cancer.

Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.

P2888

pcan.2015.22

P304

229-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PCAN.2015.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert B. Den

P577

2015-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25986914

http://www.w3.org/2001/XMLSchema#string

P921

transcriptome

biomarker

P932

4579590

http://www.w3.org/2001/XMLSchema#string

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

about

P2860

P2860

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932